Work

Machine learning reveals pre-treatment deficit accumulation as a predictor of persistent cancer-related fatigue: The Thinking and Living with Cancer longitudinal cohort study

Year: 2026
Type: article
Study design: Observational Study
Abstract: INTRODUCTION: Cancer-related fatigue is a long-term, distressing symptom among older survivors. However, predictors of fatigue are not well defined. We used machine learning to identify pre-treatment factors that predict persistent fatigue among older breast cancer survivors. MATERIALS AND METHODS: Participants were women ages ≥60 with non-metastatic breast cancer enrolled pre-systemic treatment (n = 543) and age, race, and site-matched controls without a cancer history (n = 496). Fatigue was assessed using the Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) fatigue subscale at baseline, one year, and two years; persistent fatigue was defined as ≤34 points at year one and/or two. Baseline variables included demographics, medical history, lifestyle habits, symptoms, a 46-item deficit accumulation index (DAI; an indicator of frailty) score, and cancer and treatment details (survivors only), yielding 90 variables for survivors and 82 for controls. Logistic regression with Lasso variable selection, Stochastic Gradient Boosting, Random Forest, and Boruta machine learning models were applied to assess factors that predicted persistent fatigue. RESULTS: Participants were 68.4 ± 6.1 years; 14.4% of survivors and 8.1% of controls reported persistent fatigue (p = 0.002). Model performance was strong across algorithms (corrected AUROC range: 0.74-0.83). For all participants, predictors of persistent fatigue included higher baseline fatigue, as measured using the FACIT-F total score or FACIT-F fatigue subscale score. Notably, higher pre-treatment DAI score was a strong predictor among survivors across all models (p < 0.001) but was selected by only one model for controls. DISCUSSION: Greater pre-treatment DAI score was predictive of persistent fatigue in older breast cancer survivors. Thus, a higher DAI score may be a useful clinical indicator of fatigue risk, helping target intervention efforts for these patients. CLINICALTRIALS: gov identifier:NCT03451383.
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: hybrid
Estimated APC paid: $3,610
OpenAlex ID: W7226011304
FWCI:
Cites: 46
Cited by:
Related to: 10